212 related articles for article (PubMed ID: 32926633)
1. Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs.
Hassani Najafabadi A; Zhang J; Aikins ME; Najaf Abadi ZI; Liao F; Qin Y; Okeke EB; Scheetz LM; Nam J; Xu Y; Adams D; Lester P; Hetrick T; Schwendeman A; Wicha MS; Chang AE; Li Q; Moon JJ
Nano Lett; 2020 Oct; 20(10):7783-7792. PubMed ID: 32926633
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanoma.
Aikins ME; Qin Y; Dobson HE; Najafabadi AH; Lyu K; Xu Y; Xin Y; Schwendeman A; Wicha MS; Chang AE; Li Q; Moon JJ
J Control Release; 2022 Nov; 351():872-882. PubMed ID: 36206945
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells.
Liao F; Zhang J; Hu Y; Najafabadi AH; Moon JJ; Wicha MS; Kaspo B; Whitfield J; Chang AE; Li Q
Cancer Immunol Immunother; 2022 Aug; 71(8):1959-1973. PubMed ID: 35098344
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
[TBL] [Abstract][Full Text] [Related]
5. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
Zhang S; Yang Z; Qi F
Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.
Hu Y; Lu L; Xia Y; Chen X; Chang AE; Hollingsworth RE; Hurt E; Owen J; Moyer JS; Prince ME; Dai F; Bao Y; Wang Y; Whitfield J; Xia JC; Huang S; Wicha MS; Li Q
Cancer Res; 2016 Aug; 76(16):4661-72. PubMed ID: 27325649
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.
Zheng F; Dang J; Zhang H; Xu F; Ba D; Zhang B; Cheng F; Chang AE; Wicha MS; Li Q
J Immunother; 2018 Oct; 41(8):361-368. PubMed ID: 30063587
[TBL] [Abstract][Full Text] [Related]
9. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
10. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
12. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
[TBL] [Abstract][Full Text] [Related]
13. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
14. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
[TBL] [Abstract][Full Text] [Related]
16. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling reveals an association between ALDH and oxidative phosphorylation and DNA damage repair pathways in human colon adenocarcinoma stem cells.
Wang Y; Chen Y; Garcia-Milian R; Golla JP; Charkoftaki G; Lam TT; Thompson DC; Vasiliou V
Chem Biol Interact; 2022 Dec; 368():110175. PubMed ID: 36162455
[TBL] [Abstract][Full Text] [Related]
19. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
Miyata H; Hirohashi Y; Yamada S; Yanagawa J; Murai A; Hashimoto S; Tokita S; Hori K; Abe T; Kubo T; Tsukahara T; Kanaseki T; Shinohara N; Torigoe T
Cancer Immunol Immunother; 2022 Apr; 71(4):795-806. PubMed ID: 34405274
[TBL] [Abstract][Full Text] [Related]
20. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.
Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y
Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]